APA (7th ed.) Citation

Chang, T., Lin, K., Lee, T., Tsai, Y., Chen, Y., Wu, C., & Wu, C. (2026). Comparative biological evaluation of [18F]fluciclovine, [18F]FBPA-Fr, and [18F]FET for boron neutron capture therapy: Preclinical validation and clinical feasibility. Nuclear Medicine & Biology, 156, N.PAG. https://doi.org/10.1016/j.nucmedbio.2026.109636

Chicago Style (17th ed.) Citation

Chang, Ting-Yu, Ko-Han Lin, Tzu-Yu Lee, Yi-Ting Tsai, Yi-Wei Chen, Cheng-Lin Wu, and Chun-Yi Wu. "Comparative Biological Evaluation of [18F]fluciclovine, [18F]FBPA-Fr, and [18F]FET for Boron Neutron Capture Therapy: Preclinical Validation and Clinical Feasibility." Nuclear Medicine & Biology 156 (2026): N.PAG. https://doi.org/10.1016/j.nucmedbio.2026.109636.

MLA (9th ed.) Citation

Chang, Ting-Yu, et al. "Comparative Biological Evaluation of [18F]fluciclovine, [18F]FBPA-Fr, and [18F]FET for Boron Neutron Capture Therapy: Preclinical Validation and Clinical Feasibility." Nuclear Medicine & Biology, vol. 156, 2026, p. N.PAG, https://doi.org/10.1016/j.nucmedbio.2026.109636.